ROME Therapeutics is a biotechnology company that is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome - vast stretches of uncharted genetic material that have long been dismissed as "junk DNA."
News and Articles
Hygieia is a specialty provider of insulin therapy and maker of the d-Nav Insulin Management Program. The program includes an AI-powered application that helps people with type-2 diabetes use insulin in a safe and effective way to control their blood sugar levels.
The Pepper Companies is one of the top builders of sustainable projects. They srve clients in a variety of markets including healthcare, education, commercial interiors, manufacturing and industrial, civic and cultural, data centers, entertainment, hospitality and gaming.
The Role of Minutes in Protecting Companies and Their Directors
The Light Governance Touch
The board of Quarles Petroleum Inc. allowed management the time to create and execute a response to the pandemic.
Only a handful of companies had forecast and planned for the disruptive possibilities of a pandemic, and Quarles Petroleum Inc. was not one of them. Still, this family-owned fleet fueling and propane distribution business was able not only to survive COVID-19, but also to proceed full steam ahead on its five-year strategic plan and successfully complete an acquisition. Plus, it was able to fill an open board seat.
Thank you for participating in this important survey, which was conducted by Private Company Director, Family Business Magazine and Compensation Advisory Partners.
614 usable responses were received (out of more than 750 total respondents). To be usable, a response needed to be at least 75% complete, non-duplicated by other respondents, and contain data in the proper formats.
What Will the Post-Pandemic Board of Directors Look Like?
Companies need boards built to exercise collaborative oversight with diverse skill sets.
The pandemic and other recent events are presenting new challenges for public and private companies alike, from supply chain risks to heightened shareholder concern about environmental, social and corporate governance issues. Many large organizations will need to rethink their board makeup in the new normal. The background experience and knowledge that have traditionally been sought after in board directors may not be sufficient to lead today's companies into the future.
Why Your Board of Directors Should Consider Selling (or Buying) Distressed Assets
The start of 2021 looks very different from the start of 2020. The COVID-19 pandemic was a “make or break” as many already-struggling companies went bust while others boomed.